Related Experiment Video
Updated: Apr 16, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Immune-mediated neuropathy with Epstein-Barr virus-positive T-cell lymphoproliferative disease
Takaaki Hattori1, Ayako Arai, Takanori Yokota
1Department of Neurology and Neurological Sciences, Graduate School, Tokyo Medical and Dental University, Japan.
Abstract:
A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK- cell lymphoproliferative disease (EBV-T/NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient's neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient's clinical course is not consistent with that of typical Guillain-Barré syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.
Related Concept Videos
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

